{
    "organizations": [],
    "uuid": "c536f9feb11d0f0834229207ca29f2189189403e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pacira-pharma-says-fda-posts-brief/brief-pacira-pharma-says-fda-posts-briefing-documents-for-advisory-meeting-reviewing-snda-for-exparel-idUSFWN1Q21D6",
    "ord_in_thread": 0,
    "title": "BRIEF-Pacira Pharma says FDA Posts Briefing Documents For Advisory Meeting Reviewing SNDA For Exparel",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Pacira Pharmaceuticals Inc:\n* PACIRA PHARMACEUTICALS INC - FDA POSTS BRIEFING DOCUMENTS FOR ADVISORY MEETING REVIEWING SNDA FOR EXPAREL AS A NERVE BLOCK FOR REGIONAL ANALGESIA\n* PACIRA PHARMACEUTICALS INC - ‍PRESCRIPTION DRUG USER FEE ACT DATE FOR COMPLETION OF FDA‘S REVIEW OF COMPANY‘S SNDA FOR EXPAREL IS APRIL 6, 2018​\n* PACIRA PHARMACEUTICALS INC - ADVISORY COMMITTEE MEETING IS SCHEDULED FOR FEBRUARY 14-15, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T04:04:00.000+02:00",
    "crawled": "2018-02-13T15:29:12.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "pacira",
        "pharmaceutical",
        "inc",
        "pacira",
        "pharmaceutical",
        "inc",
        "fda",
        "post",
        "briefing",
        "document",
        "advisory",
        "meeting",
        "reviewing",
        "snda",
        "exparel",
        "nerve",
        "block",
        "regional",
        "analgesia",
        "pacira",
        "pharmaceutical",
        "inc",
        "drug",
        "user",
        "fee",
        "act",
        "date",
        "completion",
        "fda",
        "review",
        "company",
        "snda",
        "exparel",
        "april",
        "pacira",
        "pharmaceutical",
        "inc",
        "advisory",
        "committee",
        "meeting",
        "scheduled",
        "february",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}